Specific Combination of Salvianolic Acids As Core Active Ingredients of Danhong Injection for Treatment of Arterial Thrombosis and Its Derived Dry Gangrene

Specific Combination of Salvianolic Acids As Core Active Ingredients of Danhong Injection for Treatment of Arterial Thrombosis and Its Derived Dry Gangrene

Blog Article

Although single-targeting anti-platelet agents are used extensively in clinics, their limitations in resistance and bleeding have started a trend of combination therapy.Danhong injection (DHI) is a widely prescribed injection medicine for cardiovascular and cerebrovascular diseases in China.However, its precise clinical efficacy and functional components remain unexplored.In this study, we investigated the anti-thrombotic role and its chemical basis of DHI.In a photochemically-induced thrombosis model, DHI effectively dissolved thrombus and ameliorated its derived dry gangrene.

DHI inhibited multiple GPCR agonists-induced platelet adhesion, aggregation and downstream Ca2+ GHR Complex and cAMP signaling pathways.A functional screen of DHI library identified its major active components as a cluster of seven salvianolic acids.A combination of salvianolic acid A and C synergistically inhibited platelet aggregation in vitro while salvianolic acid B antagonized this effect.Our study revealed the anti-thrombotic activity of DHI.The multi-targeting mechanism of DHI proves Screen Protector the effectiveness of a natural anti-thrombotic combination therapy.

The identification of salvianolic acids as a core anti-thrombotic activity of DHI and the discovery that their different combinations could either synergistically or antagonistically provide a better guidance for safer clinical application and paves the way for further development of DHI.